InvestorsHub Logo
Followers 1
Posts 260
Boards Moderated 0
Alias Born 09/11/2017

Re: Vinpat post# 9018

Tuesday, 01/07/2020 9:20:04 AM

Tuesday, January 07, 2020 9:20:04 AM

Post# of 9941
The same can be said about many of the micro / small biotechs in this space that haven't had any bump on the securing of IP through new patents. Outside of EMBI, Revive is another. Multiple patents and two recent orphan drug designations and hardly any pop from it. That's what confuses many closely tracking InMed that believe that just because they entered trials or finally get one approved patent that it will result in a big bump. Not the case in many other instances.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News